Verastem
Verastem - Novel Drugs Targeting Cancer Stem Cells. Learn more
Launch date
Employees
Market cap
CAD154m
Enterprise valuation
CAD126m (Public information from Sep 2024)
Share price
$2.71 VSTM
Needham Massachusetts (HQ)
Authorizing premium user...